Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGFR BATs in Advanced Pancreatic Cancer
NCT03269526Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Jul 2017
- Primary completion
- Jun 2023
- Modality
- Bispecific Antibodies, Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of EGFR BATs in pancreatic adenocarcinoma (PDAC), sponsored by University of Virginia. Started Jul 2017; status: completed.
02
Drugs
EGFR BATs
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03269526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269526.